Jesper Mehlsen
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
This article is a stub. |
Dr Jesper Mehlsen is a Danish clinician and researcher. He is a critical of the psychiatric / biopsychosocial treatment of ME/CFS and has advocated for it to be treated as a physical, neurological illness.[1]
ME/CFS[edit | edit source]
In 2019, Dr Mehlsen joined with many other clinicians and the patient group ME Foreningen in successfully calling for the Danish parliament to treat ME/CFS as a neurological illness with a biomedical basis rather than continuing to treat it as psychosomatic illness or functional disorder (medically unexplained symptoms),[2] and to use the World Health Organization's ICD classification. The group called upon the department of health to update it's information.[1]
Notable studies[edit | edit source]
- 2015, Is Chronic Fatigue Syndrome/Myalgic Encephalomyelitis a Relevant Diagnosis in Patients with Suspected Side Effects to Human Papilloma Virus Vaccine?[3] - (Full text) - quadrivalent vaccine
- 2018, Autonomic dysfunction and HPV immunization: an overview[4] - (Full text) - all types of vaccine
See also[edit | edit source]
Learn more[edit | edit source]
References[edit | edit source]
- ↑ 1.0 1.1 Invest in ME Research (March 1, 2019). "There is something right in the state of Denmark". www.investinme.org. Retrieved February 26, 2021. Cite has empty unknown parameter:
|dead-url=
(help) - ↑ "Tv fra Folketinget". Folketinget (in dansk). Retrieved February 26, 2021.
- ↑ Brinth, Louise; Pors, Kirsten; Hoppe, Anna AG; Badreldin, Iman; Mehlsen, Jesper (June 15, 2015). "Is Chronic Fatigue Syndrome/Myalgic Encephalomyelitis a Relevant Diagnosis in Patients with Suspected Side Effects to Human Papilloma Virus Vaccine?" (PDF). International Journal of Vaccines & Vaccination. 1 (1): 00003. doi:10.15406/ijvv.2015.01.00003. ISSN 2470-9980.
- ↑ Blitshteyn, Svetlana; Brinth, Louise; Hendrickson, Jeanne E.; Martinez-Lavin, Manuel (December 2018). "Autonomic dysfunction and HPV immunization: an overview". Immunologic Research. 66 (6): 744–754. doi:10.1007/s12026-018-9036-1. ISSN 1559-0755. PMID 30478703.